News
This study illustrates a valuable application of BID-seq to bacterial RNA, allowing transcriptome-wide mapping of pseudouridine modifications across various bacterial species. The evidence presented ...
MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on ...
Discover a study comparing besifovir with other antivirals for reducing liver cancer risk in chronic hepatitis B patients.
The Daily Galaxy on MSN
The JurAissic Experience: They’re Bringing the Dinosaurs Back to Life, and It’s Scary
The dream is as old as the first fossil pulled from the earth: What if we could see them? What if we could hear the ...
MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies ...
Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell lung cancer (NSCLC) CHICAGO, Sept. 05, 2025 (GLOBE ...
The modified nucleotide 6-thio-2’-deoxyguanosine induces telomerase-dependent telomeric DNA modification ... profound and persistent tumor regression in advanced, in vivo cancer models by induction of ...
Studying the genetics and neural mechanisms behind sneezing induced by bright light can help scientists better understand ...
In human cells, there are about 20,000 genes on a two-meter DNA strand—finely coiled up in a nucleus about 10 micrometers in ...
PARIS--(BUSINESS WIRE)--On August 24, 2025, the 23rd International Congress of Nutrition (ICN) convened in Paris, France, under the theme "Sustainable Food for Global Health." As the premier platform ...
On August 24, 2025, the 23rd International Congress of Nutrition (ICN) convened in Paris, France, under the theme "Sustainable Food for Global Health." As the premier platform in nutritional science, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results